期刊
PAEDIATRIC RESPIRATORY REVIEWS
卷 11, 期 4, 页码 246-254出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.prrv.2010.07.003
关键词
Cystic fibrosis; lung disease; treatment; Pseudomonas aeruginosa; methicillin resistant Staphylococcus aureus; Burkholderia cepacia complex; Non-tuberculous mycobacteria; Stenotrophomonas maltophilia
Cystic fibrosis (CF) lung disease is characterised by chronic inflammation and infection. Patients are predominantly infected by specific pathogens, of which Staphylococcus aureus and Pseudomonas aeruginosa are the most important. In recent years however there has been an increasing number of reports on potentially emerging and challenging pathogens like Stenotrophomonas maltophilia, Non-tuberculous mycobacteria, highly prevalent P. aeruginosa clones, methicillin resistant Staphylococcus aureus and Burkholderia cepacia. Also, a role for viral infections in the pathogenesis of CF lung disease has increasingly been recognised. It is not always clear whether or how these pathogens influence the progression of CF lung disease and how they should be treated. In this review, the epidemiology and clinical impact of these pathogens is discussed. Furthermore, treatment strategies of these pathogens in a CF setting are reviewed. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据